• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 1
      JNCCN 360 - Ovarian - Can C-reactive Protein and Serum Albumin Levels Help Determine Ovarian Cancer Severity? - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Can C-reactive Protein and Serum Albumin Levels Help Determine #OvarianCancer Severity? https://t.co/qTyXNiS5zZ #JNCCN360 #gyncsm https://t.co/1gLNP64SDb

    • Mashup Score: 5
      JNCCN 360 - Non–Small Cell Lung Cancer - Germline Variants May Play Significant Role in Lung Cancer - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Germline Variants May Play Significant Role in #LungCancer: https://t.co/QI1PNoywoJ https://t.co/B6SHO4E2z3

    • Mashup Score: 0
      JNCCN 360 - Non–Small Cell Lung Cancer - Increased Risks of Lung Cancer Among Those With Higher Genetic Sensitivity to Stress - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Increased Risks of #LungCancer Among Those With Higher Genetic Sensitivity to Stress: https://t.co/SjLn5gUOFC #JNCCN360 #lcsm https://t.co/BzRha28JXB

    • Mashup Score: 0
      JNCCN 360 - Advanced Skin Cancers - Survivn Overexpression Tied to BCC Clone Size - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Survivn Overexpression Tied to #BCC Clone Size: https://t.co/pZaX8dIgdH #JNCCN360 #skcsm https://t.co/ZDwQc1LS7A

    • Mashup Score: 0
      JNCCN 360 - CLL/MCL - What’s the Diagnosis? Positive Fecal Blood Test, Thrombocytopenia - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        What’s the Diagnosis? Positive Fecal Blood Test, Thrombocytopenia: https://t.co/7woqVrj9O7 #JNCCN360 #MCL #Lymsm https://t.co/QlTdroiJiL

    • Mashup Score: 0
      JNCCN 360 - Advanced Skin Cancers - Mohs Surgery vs Wide Local Excision in cSCC - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Mohs Surgery vs Wide Local Excision in cSCC: https://t.co/K2RSlShOfn #JNCCN360 #skcsm #surgonc https://t.co/TXgePBdlq5

    • Mashup Score: 0
      JNCCN 360 - CLL/MCL - Relapsed or Refractory MCL: Brexucabtagene Autoleucel vs Allogeneic Transplant - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Relapsed or Refractory #MCL: Brexucabtagene Autoleucel vs Allogeneic Transplant: https://t.co/ygFxAfyLcU #JNCCN360 #lymsm https://t.co/5HTgKLA0QZ

    • Mashup Score: 0
      JNCCN 360 - Ovarian - Final Results From ARIEL4: Rucaparib vs Chemotherapy for BRCA-Mutated Ovarian Cancer - 1 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Final Results From ARIEL4: Rucaparib vs Chemotherapy for #BRCA-Mutated #OvarianCancer: https://t.co/qwJNfe1a5I #JNCCN360 #gyncsm https://t.co/276aRIkXHF

    • Mashup Score: 0
      JNCCN 360 - Ovarian - Oncogene UBE2J1 Tied to High-Grade Serous Ovarian Cancer - 2 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        #Oncogene UBE2J1 Tied to High-Grade Serous #OvarianCancer: https://t.co/Fy8tMU0oBT #JNCCN360 #gyncsm https://t.co/Dsro50h3YT

    • Mashup Score: 2
      JNCCN 360 - CLL/MCL - Has Access to Multiple Agents Improved Survival in Older Patients With Mantle Cell Lymphoma? - 2 month(s) ago

      By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

      Source: jnccn360.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	JNCCN
        JNCCN

        Has Access to Multiple Agents Improved Survival in Older Patients With #MantleCellLymphoma? https://t.co/MjgIRL1eEc #JNCCN360 #lymsm https://t.co/tNYHfwVdy9

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings